CITATION

Gruessner, Rainer and Benedetti, Enrico. Living Donor Organ Transplantation. US: McGraw-Hill Professional, 2007.

Living Donor Organ Transplantation

Published:  December 2007

eISBN: 9780071593304 0071593306 | ISBN: 9780071455497
  • Contents
  • Foreword
  • Preface
  • Commentary: The Amsterdam and Vancouver Conferences on Living Organ Donation
  • Part I: General Aspects of Living Donor Organ Transplantation
  • Chapter 1 Introduction and Rationale
  • Chapter 2 Cultural Differences in Living Organ Donation: A Global Perspective
  • Chapter 3 Ethical and Legal Issues
  • 3.1 The American Perspective
  • 3.2 The Asian Perspective
  • 3.3 The European Perspective
  • Chapter 4 Donor Counseling and Consent
  • 4.1 Teaching and Testing the Knowledge and Thinking of Living Organ Donors
  • 4.2 Informed Consent
  • 4.3 Donor Advocacy
  • Chapter 5 Nondirected and Controversial Donors
  • Chapter 6 Social Issues
  • Part II: Paid Legal and Illegal Organ Donation
  • Chapter 7 Current Financial Incentives
  • 7.1 Incentives in Western Countries: The Wisconsin Model
  • 7.2 Incentives in Non-Western Countries: The Iranian Model
  • Chapter 8 Paid Legal Organ Donation
  • 8.1 Pro: The Clinician's Perspective
  • 8.2 Pro: The Philosopher's Perspective
  • 8.3 Con: The Clinician's Perspective
  • 8.4 Con: The Ethicist's Perspective
  • Chapter 9 Challenges of Paid Organ Donation for Public Health Care Policy
  • Chapter 10 Illegal Organ Trade: Global Justice and the Traffic in Human Organs
  • Chapter 11 The Impact of the Internet on Paid Legal and Illegal Organ Donation
  • Part III: Organ-Specific Aspects of Living Donor Abdominal Organ Transplantation
  • Section I: Kidney Transplantation
  • Chapter 12 Kidney Transplantation: Personal Reflections
  • Chapter 13 History of Living Donor Kidney Transplantation
  • Chapter 14 Kidney Transplantation: Geographical Differences
  • Chapter 15 Kidney Transplantation: The Donor
  • 15.1 Selection and Workup
  • 15.2 The Marginal Donor
  • 15.3 Immunologic Evaluation
  • 15.4 Anesthesiologic Considerations
  • 15.5 Surgical Procedures
  • 15.6 Perioperative Care of the Kidney Donor
  • 15.7 Donor Morbidity and Mortality
  • 15.8 Long-Term Outcome
  • 15.9 Psychological Aspects
  • Chapter 16 Kidney Transplantation: The Recipient
  • 16.1 Selection and Workup
  • 16.2 Anesthesiologic Considerations
  • 16.3 Surgical Procedures
  • 16.4 Ischemia and Reperfusion Injury
  • 16.5 Perioperative Care
  • 16.6 Posttransplant Complications
  • 16.7 Immunosuppressive Therapy
  • 16.8 Immunobiology
  • 16.9 Recurrence of Disease
  • 16.10 Retransplantation
  • 16.11 Pediatric Issues
  • 16.12 Preemptive Living Transplantation: The Ideal Therapeutic Modality for End-Stage Renal Disease
  • 16.13 Long-Term Outcome
  • 16.14 Immunologic Issues
  • 16.15 Living Donor Kidney Transplantation and Malignancy
  • 16.16 Strategies to Maximize the Donor Pool
  • Chapter 17 Kidney Transplantation: Cost Analysis
  • Section II: Pancreas Transplantation
  • Chapter 18 History of and Rationale for Pancreas Transplantation
  • 18.1 History of Living Donor Pancreas Transplantation
  • 18.2 Rationale for Living Donor Pancreas Transplants
  • Chapter 19 Pancreas Transplantation: The Donor
  • 19.1 Selection and Workup
  • 19.2 Surgical Procedures and Perioperative Care
  • 19.3 Morbidity, Mortality, and Long-Term Outcome
  • Chapter 20 Pancreas Transplantation: The Recipient
  • 20.1 Selection and Workup
  • 20.2 Surgical Procedures
  • 20.3 Perioperative Care, Immunosuppressive Therapy, and Posttransplant Complications
  • 20.4 The Identical Twin Transplant Experience: Recurrence of Disease
  • Chapter 21 Registry Report and Long-Term Outcome
  • Chapter 22 Islet Autotransplantation after Pancreatectomy: History and Outcomes
  • Chapter 23 Islet Transplantation Using Living Donors
  • Section III: Liver Transplantation
  • Chapter 24 Personal Reflections and History of Living Donor Liver Transplantation
  • Chapter 25 Regional Variations in The U.S. Living Donor Experience
  • Chapter 26 Institutional Needs for Living Donor: Liver Transplantation
  • Chapter 27 Role of Split Liver Transplantation from Deceased Donors: Lessons Learned
  • Chapter 28 Liver Regeneration
  • Chapter 29 Living Donor Liver Transplantation: The Donor
  • 29.1 Selection and Workup
  • 29.2 Anesthesiologic Considerations
  • 29.3 Surgical Procedures
  • 29.4 Perioperative Care
  • 29.5 Donor Morbidity and Mortality
  • 29.6 Long-Term Donor Outcomes
  • 29.7 Psychological Aspects
  • Chapter 30 Liver Transplantation: The Recipient
  • 30.1 Selection and Workup
  • 30.2 Anesthesiologic Considerations
  • 30.3 Surgical Procedures
  • 30.4 Optimized Venous Outflow
  • 30.5 Ischemia and Reperfusion Injury
  • 30.6 Small-for-Size Grafts
  • 30.7 Perioperative Care of the Liver Recipient
  • 30.8 Posttransplant Complications
  • 30.9 Interventional Therapies
  • 30.10 Immunosuppressive Therapy
  • 30.11 Immunobiology
  • 30.12 Controversial Indications
  • 30.13 Domino Liver Transplantation
  • 30.14 Liver Retransplantation
  • 30.15 Long-Term Outcome
  • 30.16 Strategies to Maximize the Donor Pool
  • Chapter 31 Liver Transplantation: Cost Analysis
  • Section IV: Intestinal Transplantation
  • Chapter 32 History of Living Donor Intestinal Transplantation
  • Chapter 33 Intestinal Transplantation – The Donor
  • 33.1 Selection and Workup
  • 33.2 Surgical Procedures and Perioperative Care
  • 33.3 Morbidity, Mortality, Long-Term Outcome
  • Chapter 34 Intestinal Transplantation – The Recipient
  • 34.1 Selection and Workup
  • 34.2 Surgical Procedures and Perioperative Care
  • 34.3 Immunosuppressive Therapy and Postoperative Complications
  • 34.4 Pathology of Small Bowel Transplantation
  • 34.5 Registry Report and Long-Term Outcome
  • 34.6 Intestinal Transplantion: Cost Analysis
  • Part IV: Future Developments and Alternatives to Living Donor Transplantation
  • Chapter 35 Dual-Organ Donation
  • Chapter 36 Use of Living Donors for HIV-Positive Transplant Candidates
  • Chapter 37 New Immunosuppressive Protocols
  • Chapter 38 Strategies to Induce Tolerance
  • Chapter 39 Xenotransplantation
  • Chapter 40 Gene Therapy
  • Chapter 41 Organogenesis and Cloning
  • Index